Skip to content

The Parkinson's Genetic Research Study

The Parkinson's Genetic Research Study (PaGeR)

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT01558479
Acronym
PaGeR
Enrollment
5000
Registered
2012-03-20
Start date
2009-09-30
Completion date
2026-10-31
Last updated
2024-05-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Parkinson's Disease

Keywords

Parkinson's Disease, Genetics, Family Research, Hereditary Neurodegenerative Diseases

Brief summary

The Parkinson's Genetic Research Study (PaGeR), headed by Dr. Cyrus Zabetian, is searching for genes that increase the risk of developing Parkinson's disease (PD) and related disorders. The study is a joint effort by neurologists and researchers across the United States and is sponsored by the National Institutes of Health. The coordinating center for PaGeR is located at the University of Washington and the VA Puget Sound Health Care System in Seattle.

Detailed description

PaGeR is focusing on families in which two or more people have been diagnosed with PD. Past research suggests that such multiplex families might hold the key to the discovery of new PD genes. To take part in PaGeR, participants will be asked to complete a questionnaire and to undergo an interview, a neurological exam, a short memory test, and a blood draw. Enrollment in the study usually takes between one and two hours. There is no cost to participate, and all study information is kept strictly confidential. There are a number of designated sites across the country where families can enroll. However, for family members who are unable to travel to one of these sites, other arrangements can be made.

Interventions

None listed

Sponsors

University of Washington
Lead SponsorOTHER

Study design

Observational model
FAMILY_BASED
Time perspective
CROSS_SECTIONAL

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* Over 18 years of age * Member of a family in which there are two or more living individuals who have been diagnosed with Parkinson's disease

Exclusion criteria

* Under 18 years of age

Countries

United States

Contacts

Primary ContactJennifer Pate
1-855-646-4221
Backup ContactKhryss Capawa
kcapawa@uw.edu(206) 277-3956

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026